A Randomized, Phase 3, Open-label Trial Comparing the Effect of Tirzepatide Once Weekly Versus Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes on Metformin With or Without a Sulfonylurea
收藏DataCite Commons2025-07-02 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00008976/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The main reason for this study is to compare the study drug tirzepatide to insulin glargine
in participants with type 2 diabetes on metformin with or without a sulfonylurea.
提供机构：
Vivli
创建时间：
2023-05-26
